176 results
Page 4 of 9
8-K
EX-99.1
ffc9qc 52
27 Oct 21
Alkermes plc Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.2
11j jk1ti3
27 Oct 21
Alkermes plc Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.2
xerg4 bg6if1lmx
28 Jul 21
Alkermes plc Reports Second Quarter 2021 Financial Results
7:05am
DEFA14A
wo2f97kbjgos8 6co3
8 Jun 21
Additional proxy soliciting materials
4:15pm
8-K
EX-99.1
5ijofatq6tgerjl6i
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am
8-K
EX-99.2
wj4sm36u3 fut81p
28 Apr 21
Alkermes plc Reports First Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
i8tij6 36d6ovjtoba
28 Apr 21
Alkermes plc Reports First Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
laknvashmo 7gk38ul7
25 Mar 21
Regulation FD Disclosure
12:00am
8-K
EX-99.2
ordclegoejgnb
11 Feb 21
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
lmtmdvf4
11 Feb 21
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
1l35f5hkrne8syhmnng
11 Jan 21
Regulation FD Disclosure
7:00am
8-K
EX-10.1
c6qgaf lqxf
10 Dec 20
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
7:19am